期刊文献+

冠状动脉介入术患者对比剂肾病的相关危险因素分析 被引量:8

Contrast-induced nephropathy in patients undergoing coronary intervention
暂未订购
导出
摘要 目的:研究冠状动脉造影(CAG)和经皮冠状动脉介入治疗(PCI)患者对比剂肾病(CIN)的发病率及危险因素。方法:选择2010年10月至2011年4月南京军区南京总医院接受CAG和PCI的患者672例,以术后48h血清肌酐(SCr)较术前升高25%或升高44.2μmol/L(0.5mg/dl)作为CIN的诊断标准,分析CIN的发病率及危险因素。结果:672例患者中,年龄≥65岁者292例(43.5%),冠心病588例(87.5%),高血压461例(68.6%),糖尿病144例(21.4%),术前SCr≥110μmol/L者30例(4.5%),贫血42例(6.3%),服用血管紧张素转换酶抑制剂344例(51.2%),利尿剂95例(14.1%),二甲双胍39例(5.8%),对比剂用量≥200ml者237例(35.3%)。672患者中55例(8.2%)发生CIN,发生CIN者与非CIN者在年龄≥65岁、冠心病、对比剂用量≥200ml及利尿剂等方面有明显差异(P<0.05)。Logistic多因素回归分析显示,年龄≥65岁、对比剂用量≥200mL是CIN的独立危险因素。结论:在CAG和PCI患者的CIN发病率较高,年龄≥65岁和对比剂用量≥200mL是其独立危险因素。 Objective : To investigate the incidence and the rick factors of contrast-induced nephropathy (CIN) in patients undergoing coronary angiography (CAG) and percutaneous coronary intervention (PCI). Methodology: From October 2010 to April 2011, a total of six hundred and seventy two cases undergoing CAG and PCI were recruited. CIN is identified if the serum creatinine is increased by 25% or 44. 2 μmol/L (0. 5 mg/dl) of the baseline at 48 hours post procedure. The incidence and the rick factors of CIN were analyzed. Results:Of six hundred and seventy two patients, 292 cases (43.5%) were aged over ≥65 588 (87.5%) had coronary heart disease,461 (68.6%)had hypertension,144 (21.4%) had diabetes mellitus,30 (4. 5% ) had SCr more than 110 μmol/L before procedure,42 (6. 3% ) had anemia, 344 (51.2%) took ACEI,95 ( 14. 1% ) took diuretics,39 (5.8%) took metformins,and 237 cases (35.3%) had the volume of contrast media ≥200 ml. Among the 672 patients,CIN occurred in 55 patients and the incidence of CIN was 8. 2%. There were significant differences between CIN and non-CIN patients in terms of ages over 65, coronary heart disease, the volume of contrast meida ≥200 ml. diuretics (P 〈 0. 05 ). Logistic regression analysis showed that age ≥65, and the voluem of contrast media ≥200 ml were independent risk factors of CIN. Conclusion:The incidence of CIN in patients undergoing CAG and PCI was higher. The age ≥65 and the volume of contrast meida ≥200 ml were independent risk factors of CIN.
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2012年第1期24-28,共5页 Chinese Journal of Nephrology,Dialysis & Transplantation
关键词 冠状动脉介入术 对比剂肾病 危险因素 percutaneous coronary intervention contrast-induced nephropathy risk factor
  • 相关文献

参考文献23

  • 1Darwish T.An evidence-based approach to minimise contrast-induced nephropathy.N Z Med J,2009,122(1299):39-41.
  • 2Solomon RJ,Mehran R,Natarajan MK,et al.Contrast-induced nephropathy and long-term adverse events:cause and effect? Clin J Am Soc Nephrol,2009,4(7):1162-1169.
  • 3Toprak O.Risk markers for contrast-induced nephropathy.Am J Med Sci,2007,334(4):283-290.
  • 4Wong GT,Irwin MG.Contrast-induced nephropathy.Br J Anaesth,2007,99(4):474-483.
  • 5王兆星,陈海平.造影剂肾病早期诊断的生物标志物[J].肾脏病与透析肾移植杂志,2011,20(3):275-279. 被引量:10
  • 6Cavusoglu E,Chhabra S,Marmur JD,et al.The prevention of contrastinduced nephropathy in patients undergoing percutaneous coronary intervention.Minerva Cardioangiol,2004,52(5):419-432.
  • 7Rihal CS,Textor SC,Grill DE,et al.Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention.Circulation,2002,105(19):2259-2264.
  • 8Cowburn PJ,Patel H,Pipes RR,et al.Contrast nephropathy post cardiac resynchronization therapy:an under-recognized complication with important morbidity.Eur J Heart Fail,2005,7(5):899-903.
  • 9Toprak O,Cirit M,Yesil M,et al.Metabolic syndrome as a risk factor for contrast-induced nephropathy in non-diabetic elderly patients with renal impairment.Kidney Blood Press Res,2006,29(1):2-9.
  • 10Bruce RJ,Djamali A,Shinki K,et al.Background fluctuation of kidney function versus contrast-induced nephrotoxicity.A JR Am J Roentgenol,2009,192(3):711-718.

二级参考文献15

  • 1孙蔚明,杜晔.非离子型造影剂致肾损害的临床分析[J].中国医学影像学杂志,2005,13(4):284-287. 被引量:24
  • 2张庆娟(综述),刘殿阁(审校).造影剂肾病的防治进展[J].国际泌尿系统杂志,2007,27(1):117-120. 被引量:15
  • 3张晓伟,丛占杰,王文龙.视黄醇结合蛋白检测在观察高血压及糖尿病早期肾脏改变中的应用[J].中国实验诊断学,2007,11(2):187-189. 被引量:19
  • 4陈星荣.对比剂副作用预防和进展.中华放射学杂志,1986,20:70-70.
  • 5MacNeiU BD, Harding SA, Bazari H, et al. Prophylaxis of contrast induced nephropathy in patients undergoing coronary angiography [ J ], Catheter Cardiovasc Interv, 2003,60:458 - 461.
  • 6Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy[J]. J Am Soc Nephrol, 2000,11:177- 182.
  • 7Folkman J, Beckner K. Angiogenesis imaging[J]. Acad Radiol,2000, 7:783 - 785.
  • 8Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in highrisk patients undergoing angiography[J]. N Engl J Med, 2003, 348: 491 - 499.
  • 9Berg KJ. Nephrotoxicity related to eontrast media [ J]. Scand J Urol Nephrol, 2000,34:5317 - 5322.
  • 10Barrett B J, Parfrey PS. Contrast nephropathy in the patients with impaired renal function: high versus low osmolar media[J]. Kidney Int, 1992,41 : 1274 - 1279.

共引文献12

同被引文献68

  • 1陆佑明,杨威.乌司他丁对老年2型糖尿病病人围术期凝血功能的影响[J].医学临床研究,2012,29(6). 被引量:2
  • 2叶飞,陈芳,邹冬梅,屈靖.高通量血液透析治疗慢性肾病患者的临床疗效观察[J].医学临床研究,2012,29(6). 被引量:7
  • 3王沆,郭平凡.造影剂肾病[J].医学综述,2007,13(8):594-596. 被引量:18
  • 4Agrawal M, Stouffer GA. Contrast induced nephropathy after angiography[J]. Am Mt Sci. 2002,223 : 252.
  • 5Idee JM, Lancelot E, Bertholam ier C. Effect of non-- ionic-- monomerle and dime ciodinated Contrast media on renal and syslemie haemodynamies in rats. Fundam Clin J Pharmaeol,2000,14 : 11 - 18.
  • 6McCullough PA. Acute kidney injury with iodinated contrast [J]. Crit Care Med,2008,36(6) :204-211.
  • 7Park DW, Yun SC, Lee JY, et al. C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-elu- ting stentimplantation. Circulation,2009,120(7):1987-1995.
  • 8李瑞建.动脉粥样硬化未干预病变斑块易损机制的实验及临床研究.山东大学,2013.
  • 9屈展.二甲双胍对肝癌细胞体内外增殖及凋亡的影响及其机制研究.中南大学学报,2012.
  • 10Mccullough PA.Contrast-Induced acute kidey injury [J].J Am Coll Cardiol, 2014,61( 11 ) : 1652-1657.

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部